BECKY ALLEN: Open Payments
NPI 1386328193 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,712 in 60 payments from 12 companies in 2025. Trend: 2023 $188 · 2024 $1,124 · 2025 $1,712
Food & beverage: $1,712
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $456 |
| Vanda Pharmaceuticals Inc. | 8 | $280 |
| ABBVIE INC. | 17 | $279 |
| Axsome Therapeutics, Inc. | 4 | $171 |
| Otsuka America Pharmaceutical, Inc. | 4 | $167 |
| Neurocrine BioSciences, Inc. | 6 | $118 |
| Teva Pharmaceuticals USA, Inc. | 5 | $86 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
Products named: CAPLYTA, VRAYLAR, Auvelity, HETLIOZ, REXULTI, FANAPT, INGREZZA, UZEDY.
Industry payments across KY — which companies pay providers there.
